Search | IOVS | ARVO Journals

Showing 1 – 20 of 105

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

Detection of outlying practitioners for the treatment of neovascular age-related macular degeneration with anti-vascular endothelial growth factor agents

Yohei Hashimoto; Mark C Gillies

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):1364.

ARVO Annual Meeting Abstract June 2024

Long Term Outcomes for Neovascular Age-related Macular Degeneration in a Frugal Country: The Netherlands

Haras Mhmud; Odette M Tigchelaar-Besling; Jeroen Vermeulen; Frank D Verbraak; Daniel Barthelmes; Mark C Gillies; Dirk Ponsioen; Caroline C W Klaver

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2118.

ARVO Annual Meeting Abstract June 2024

Six-Month Outcomes of Switching to Faricimab in Eyes with Neovascular Age-Related Macular Degeneration

Mark C Gillies

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):256.

ARVO Annual Meeting Abstract June 2024

Exploring the Effects of 1-Deoxysphingolipids on Human Macula: Insights from the Macula-on-a-Chip (MoaC) System

Yue Zeng; Ting Zhang; Michelle Yam; So-Ra Lee; Jialing Zhang; Shaoxue Zeng; Yingying Chen; Meidong Zhu; Meixia Zhang; Kevin Thomas Eade; Ling Zhu; Mark C Gillies

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):1697.

ARVO Annual Meeting Abstract June 2024

Sacrificing Adaptability for Functionality: The Ivory Tower of Macular Müller Cells

Ling Zhu; Ting Zhang; Kaiyu Jin; Shaoxue Zeng; Penghui Yang; Meidong Zhu; Jialing Zhang; Yingying Chen; So-Ra Lee; Michelle Yam; Yue Zeng; Andrew Chang; Jianhai Du; Xiaohui Fan; Mark C Gillies; Xiaoyan Lu

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):1679.

ARVO Annual Meeting Abstract June 2024

Linking multimodal image-linkage with the FRB! registry to enhance its globally impactful research potential – the beginning of “FRB! 2.0”.

Ash Kras; Mark C Gillies; Jennifer Arnold; Daniel Barthelmes; Hemal Mehta

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):5631.

ARVO Annual Meeting Abstract June 2024

A double-masked, Placebo-Controlled, Phase 1b/2a Study of EXN407 Eye Drops in Patients with Mild Center Involving Diabetic Macular Edema (DME)

loic Cm lhuillier; Hemal Mehta; Jagjit Gilhotra; Fred Chen; Sanjeewa Wickremasinghe; Wilson Heriot; Peter Davies; Lily Ooi; Jennifer Arnold; Rohan Merani; Mike Taylor; David O Bates; Samantha Fraser-Bell; Mark C Gillies; Mario G Fsadni; Andrew Chang

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):6248.

ARVO Annual Meeting Abstract June 2024

Differential Roles of 2-Tail and 3-Tail Phospholipids in LNPs for RNA Delivery to the Human Retina

Shaoxue Zeng; Kaiyu Jin; Ting Zhang; Jialing Zhang; Xiaohui Fan; Wojciech Chrzanowski; Mark C Gillies; Ling Zhu

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):6166.

ARVO Annual Meeting Abstract June 2022

36-month outcomes of VEGF inhibitors for treatment-naïve Central Retinal Vein Occlusion: Data from the Fight Retinal Blindness! registry.

Adrian Hunt; Vuong Nguyen; Sanjeeb Bhandari; Jennifer J Arnold; Ian McAllister; Hemal Mehta; Alessandro Invernizzi; David Squirrell; Theodorus Ponsioen; Pierre-Henry GABRIELLE; Louise O’ Toole; Javier Zarranz-Ventura; Daniel Barthelmes; Mark C Gillies

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2674.

ARVO Annual Meeting Abstract June 2022

Incidence, Risk Factors and Outcomes of Submacular Hemorrhage with Loss of Vision in Neovascular Age-Related Macular Degeneration in Daily Clinical Practice: the Fight Retinal Blindness! Registry

Pierre-Henry GABRIELLE; Vuong Nguyen; Jennifer J Arnold; David Squirrell; Louis Arnould; Jorge Sanchez-Monroy; Francesco Viola; Louise O’ Toole; Daniel Barthelmes; Catherine Creuzot-Garcher; Mark C Gillies

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1344 – F0178.

ARVO Annual Meeting Abstract June 2022

Jak/STAT signalling mediated glia-neuron interaction following MAPK inhibition

Shaoxue Zeng; Ting Zhang; Yingying Chen; Kaiyu Jin; Xiaohui Fan; Ling Zhu; Mark C Gillies

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1176 – A0030.

ARVO Annual Meeting Abstract June 2022

Reprogramming of serine and glycine synthesis pathway in the JR5558 mouse model of retinal fibrosis

Ting Zhang; Ling Zhu; So-Ra Lee; Shaoxue Zeng; Yingying Chen; Michelle Yam; Mark C Gillies

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2478 – F0185.

ARVO Annual Meeting Abstract June 2022

Metallothionein is activated specifically in Müller cells in response to retinal stress

Ling Zhu; Ting Zhang; Kaiyu Jin; Shaoxue Zeng; Yingying Chen; So-Ra Lee; Michelle Yam; Fanfan Zhou; Xiaohui Fan; Mark C Gillies

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):4122 – F0359.

ARVO Annual Meeting Abstract June 2021

JR5558 transgenic mice are a reliable model to investigate subretinal fibrosis

Yashar Seyed-Razavi; So-Ra Lee; Jiawen Fan; Weiyong Shen; Mark C Gillies

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):2253.

ARVO Annual Meeting Abstract June 2021

Quality of life impact of eye diseases: a Save Sight Registries study

Himal Kandel; Vuong Nguyen; Mark C Gillies; Stephanie L Watson

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):3495.

ARVO Annual Meeting Abstract June 2021

Extending interoperability in ophthalmology through Fast Healthcare Interoperability Resource (FHIR)

Ashley Kras; Warren Oliver; Mark C Gillies; Michael Mair; Stephen Chu; Nigel Morlet; Michael Mbagwu; Thomas S Hwang; Matthew Roe; Theordore Leng

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1708.

ARVO Annual Meeting Abstract June 2021

Disruption of the pentose phosphate pathway in Müller cells makes them more susceptible to light stress by interfering with the oxidative stress-induced NRF2 response

Yingying Chen; Ting Zhang; Shaoxue Zeng; Kaiyu Jin; Rong Xu; Xiaohui Fan; Meixia Zhang; Jianhai Du; Mark C Gillies; Ling Zhu

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1667.

ARVO Annual Meeting Abstract June 2021

COVID-19 pandemic lockdown international impact on nAMD, DME and RVO intravitreal therapy outcomes: Fight Retinal Blindness International registry

Javier Zarranz-Ventura; Vuong Nguyen; Catherine P Creuzot Garcher; Frank D Verbraak; Louise OToole; Alessandro Invernizzi; Francesco Viola; David Squirrell; Daniel Barthelmes; Mark C Gillies

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):311.

ARVO Annual Meeting Abstract June 2021

Variation in visual outcomes for neovascular age-related macular degeneration within and between practitioners

Vuong Nguyen; Daniel Barthelmes; Mark C Gillies

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):455.

ARVO Annual Meeting Abstract June 2020

Disease Activity Assessments with Brolucizumab vs Aflibercept in Patients with nAMD in HAWK and HARRIER

Rishi P Singh; Robin Hamilton; Jeffrey S Heier; Carl Regillo; Mark C Gillies; Georges Weissgerber; Jahangir Alam; Pravin U Dugel

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):1158.

1 2 3 4 5

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Detection of outlying practitioners for the treatment of neovascular age-related macular degeneration with anti-vascular endothelial growth factor agents

Long Term Outcomes for Neovascular Age-related Macular Degeneration in a Frugal Country: The Netherlands

Six-Month Outcomes of Switching to Faricimab in Eyes with Neovascular Age-Related Macular Degeneration

Exploring the Effects of 1-Deoxysphingolipids on Human Macula: Insights from the Macula-on-a-Chip (MoaC) System

Sacrificing Adaptability for Functionality: The Ivory Tower of Macular Müller Cells

Linking multimodal image-linkage with the FRB! registry to enhance its globally impactful research potential – the beginning of “FRB! 2.0”.

A double-masked, Placebo-Controlled, Phase 1b/2a Study of EXN407 Eye Drops in Patients with Mild Center Involving Diabetic Macular Edema (DME)

Differential Roles of 2-Tail and 3-Tail Phospholipids in LNPs for RNA Delivery to the Human Retina

36-month outcomes of VEGF inhibitors for treatment-naïve Central Retinal Vein Occlusion: Data from the Fight Retinal Blindness! registry.

Incidence, Risk Factors and Outcomes of Submacular Hemorrhage with Loss of Vision in Neovascular Age-Related Macular Degeneration in Daily Clinical Practice: the Fight Retinal Blindness! Registry

Jak/STAT signalling mediated glia-neuron interaction following MAPK inhibition

Reprogramming of serine and glycine synthesis pathway in the JR5558 mouse model of retinal fibrosis

Metallothionein is activated specifically in Müller cells in response to retinal stress

JR5558 transgenic mice are a reliable model to investigate subretinal fibrosis

Quality of life impact of eye diseases: a Save Sight Registries study

Extending interoperability in ophthalmology through Fast Healthcare Interoperability Resource (FHIR)

Disruption of the pentose phosphate pathway in Müller cells makes them more susceptible to light stress by interfering with the oxidative stress-induced NRF2 response

COVID-19 pandemic lockdown international impact on nAMD, DME and RVO intravitreal therapy outcomes: Fight Retinal Blindness International registry

Variation in visual outcomes for neovascular age-related macular degeneration within and between practitioners

Disease Activity Assessments with Brolucizumab vs Aflibercept in Patients with nAMD in HAWK and HARRIER

To View More...

You must be signed into an individual account to use this feature.